The latest market report published by Credence Research, Inc. “Global Infection Surveillance Solutions Market By Product (Services and Software), By Type (Urinary Tract Infection, Surgical Site Infection, Blood Stream Infection and Others), By End-Use (Hospitals, Long Term Care Centers and Others) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026,” the global infection surveillance solutions market is set to grow from US$ 330.7 Mn in 2017 to US$ 934.7 Mn 2026 expanding at a CAGR of 12.4% from 2018 to 2026.
Browse the full report Infection Surveillance Solutions Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/infection-surveillance-solutions-market
Market Insights
Lack of sanitation, non-adherence to prescribed medication and increasing trend of self-medication has resulted in antibiotic resistance by bacteria. There is urgent requirement of surveillance system to keep in check the proliferation of hospital acquired infection and mortality associated with dreadful diseases such as pneumonia, tuberculosis, ebola, malaria etc. Rising public health awareness and proactive government policies to curb the deleterious effect associated with infectious disease drive the infection surveillance solutions market growth.
Software solutions are garnering huge growth in the product segment for infection surveillance solutions market. Ability to monitor infectious disease in primary healthcare centers and rampant growth in global IT-healthcare sector drive the software solutions market growth. Services are growing at a steady pace due to entry of numerous market participants providing outsourcing solutions pertaining to infection surveillance.
Urinary tract infection is reigning the type segment for infection surveillance solutions market. Prolonged use of catheter and increasing number of immunocompromised patients drive the urinary tract infection. Other infections such as MRSA and pneumonia will register impressive growth due to growing antibiotic resistance and lack of treatment regimen to counteract its deleterious effect.
Hospitals are currently dominating the end-use segment for infection surveillance solutions market. Significant rise in the number of surgeries performed and increasing number of inbound patients drive the hospitals market growth. Long term care centers will be growing at a faster pace on account of its ability to treat patients suffering with antibiotic resistance by microorganism and increasing outbound patients due to low healthcare cost incurred.
North America is the clear leader in regional segment for infection surveillance solutions with 35% market share. The major contributing factors related to its overwhelming market growth are increasing cases of hospital acquired infections and existence of well-developed healthcare framework. Europe with a share of 30% is the second largest regional market owing to proactive government policies in reducing mortality associated with infectious disease and increasing funding in life science research and development segment to counteract antibiotic resistance by bacteria. Asia Pacific represents 20% share on account of increasing healthcare burden on primary healthcare centers associated with infectious disease and rising public health awareness.
IT-healthcare companies pioneering in providing infection surveillance solutions are Becton Dickinson and Company, Deb Group, Ltd., Gojo Industries, Inc., Baxter International, Inc., Truven Health Analytics, Hygreen, Inc., Premier, Inc., Atlas Medical Software, RL Solutions and Wolters Kluwer N.V.
Key Market Movements:
Rising prevalence of infectious disease and antibiotic resistance by bacteria
Availability of different configuration solutions making real time infection surveillance successful
Increasing number of primary healthcare centers and IT-healthcare market participants worldwide
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59586
Table of Content
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Infection Surveillance Solutions Market Portraiture
2.2. Global Infection Surveillance Solutions Market, by Product, 2017 (US$ Mn)
2.3. Global Infection Surveillance Solutions Market, by Type, 2017 (US$ Mn)
2.4. Global Infection Surveillance Solutions Market, by End-Use, 2017 (US$ Mn)
2.5. Global Infection Surveillance Solutions Market, by Geography, 2017 (US$ Mn)
Chapter 3. Infection Surveillance Solutions Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Infection Surveillance Solutions Market, by Key Players, 2017
Chapter 4. Global Infection Surveillance Solutions Market, by Product
4.1. Overview
4.2. Services
4.3. Software
Chapter 5. Global Infection Surveillance Solutions Market, by Type
5.1. Urinary Tract Infection
5.2. Surgical Site Infection
5.3. Blood Stream Infection
5.4. Others
Chapter 6. Global Infection Surveillance Solutions Market, by End-Use
6.1. Overview
6.2. Hospitals
6.3. Long Term Care Centers
6.4. Others
Chapter 7. Global Infection Surveillance Solutions Market, by Geography
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America (LATAM)
7.5. Middle East and Africa (MEA)
Chapter 8. Company Profiles
8.1. Atlas Medical Software
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Becton Dickinson and Comp
Chris Smith
Credence Research
sales@credenceresearch.com
https://www.credenceresearch.com/report/infection-surveillance-solutions-market